• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

草药在与线粒体介导的氧化应激相关的肝脏疾病中的潜在治疗意义

Potential Therapeutic Implication of Herbal Medicine in Mitochondria-Mediated Oxidative Stress-Related Liver Diseases.

作者信息

Park Moon Nyeo, Rahman Md Ataur, Rahman Md Hasanur, Kim Jong Woo, Choi Min, Kim Jeong Woo, Choi Jinwon, Moon Myunghan, Ahmed Kazi Rejvee, Kim Bonglee

机构信息

Department of Pathology, College of Korean Medicine, Kyung Hee University, Hoegi-dong, Dongdaemun-gu, Seoul 02447, Korea.

Korean Medicine-Based Drug Repositioning Cancer Research Center, College of Korean Medicine, Kyung Hee University, Seoul 02447, Korea.

出版信息

Antioxidants (Basel). 2022 Oct 17;11(10):2041. doi: 10.3390/antiox11102041.

DOI:10.3390/antiox11102041
PMID:36290765
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9598588/
Abstract

Mitochondria are double-membrane organelles that play a role in ATP synthesis, calcium homeostasis, oxidation-reduction status, apoptosis, and inflammation. Several human disorders have been linked to mitochondrial dysfunction. It has been found that traditional therapeutic herbs are effective on alcoholic liver disease (ALD) and nonalcoholic fatty liver disease (NAFLD) which are leading causes of liver cirrhosis and hepatocellular carcinoma. The generation of reactive oxygen species (ROS) in response to oxidative stress is caused by mitochondrial dysfunction and is considered critical for treatment. The role of oxidative stress, lipid toxicity, and inflammation in NAFLD are well known. NAFLD is a chronic liver disease that commonly progresses to cirrhosis and chronic liver disease, and people with obesity, insulin resistance, diabetes, hyperlipidemia, and hypertension are at a higher risk of developing NAFLD. NAFLD is associated with a number of pathological factors, including insulin resistance, lipid metabolic dysfunction, oxidative stress, inflammation, apoptosis, and fibrosis. As a result, the improvement in steatosis and inflammation is enough to entice researchers to look into liver disease treatment. However, antioxidant treatment has not been very effective for liver disease. Additionally, it has been suggested that the beneficial effects of herbal medicines on immunity and inflammation are governed by various mechanisms for lipid metabolism and inflammation control. This review provided a summary of research on herbal medicines for the therapeutic implementation of mitochondria-mediated ROS production in liver disease as well as clinical applications through herbal medicine. In addition, the pathophysiology of common liver disorders such as ALD and NAFLD would be investigated in the role that mitochondria play in the process to open new therapeutic avenues in the management of patients with liver disease.

摘要

线粒体是具有双层膜的细胞器,在三磷酸腺苷(ATP)合成、钙稳态、氧化还原状态、细胞凋亡和炎症中发挥作用。几种人类疾病已被证明与线粒体功能障碍有关。研究发现,传统治疗草药对酒精性肝病(ALD)和非酒精性脂肪性肝病(NAFLD)有效,这两种疾病是肝硬化和肝细胞癌的主要病因。线粒体功能障碍会导致氧化应激反应中产生活性氧(ROS),这一过程被认为对治疗至关重要。氧化应激、脂质毒性和炎症在NAFLD中的作用已为人所知。NAFLD是一种慢性肝病,通常会发展为肝硬化和慢性肝病,肥胖、胰岛素抵抗、糖尿病、高脂血症和高血压患者患NAFLD的风险更高。NAFLD与多种病理因素有关,包括胰岛素抵抗、脂质代谢功能障碍、氧化应激、炎症、细胞凋亡和纤维化。因此,脂肪变性和炎症的改善足以吸引研究人员探索肝病治疗方法。然而,抗氧化治疗对肝病的效果并不理想。此外,有研究表明,草药对免疫和炎症的有益作用受脂质代谢和炎症控制的多种机制影响。本综述总结了草药在肝病治疗中通过线粒体介导的ROS生成的治疗应用以及临床应用方面的研究。此外,还将研究ALD和NAFLD等常见肝病的病理生理学,以及线粒体在这一过程中所起的作用,为肝病患者的治疗开辟新的途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78c7/9598588/7dbb17684d2f/antioxidants-11-02041-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78c7/9598588/0ddcb4fe0a80/antioxidants-11-02041-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78c7/9598588/76d3a6c301e7/antioxidants-11-02041-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78c7/9598588/46774830b1bb/antioxidants-11-02041-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78c7/9598588/68891d04eb05/antioxidants-11-02041-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78c7/9598588/10eff6897354/antioxidants-11-02041-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78c7/9598588/7dbb17684d2f/antioxidants-11-02041-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78c7/9598588/0ddcb4fe0a80/antioxidants-11-02041-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78c7/9598588/76d3a6c301e7/antioxidants-11-02041-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78c7/9598588/46774830b1bb/antioxidants-11-02041-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78c7/9598588/68891d04eb05/antioxidants-11-02041-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78c7/9598588/10eff6897354/antioxidants-11-02041-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78c7/9598588/7dbb17684d2f/antioxidants-11-02041-g006.jpg

相似文献

1
Potential Therapeutic Implication of Herbal Medicine in Mitochondria-Mediated Oxidative Stress-Related Liver Diseases.草药在与线粒体介导的氧化应激相关的肝脏疾病中的潜在治疗意义
Antioxidants (Basel). 2022 Oct 17;11(10):2041. doi: 10.3390/antiox11102041.
2
Herbal Medicine in the Treatment of Non-Alcoholic Fatty Liver Diseases-Efficacy, Action Mechanism, and Clinical Application.草药医学治疗非酒精性脂肪性肝病——疗效、作用机制及临床应用
Front Pharmacol. 2020 May 12;11:601. doi: 10.3389/fphar.2020.00601. eCollection 2020.
3
Chinese herbal medicines: The modulator of nonalcoholic fatty liver disease targeting oxidative stress.中草药:针对氧化应激的非酒精性脂肪肝疾病调节剂。
J Ethnopharmacol. 2024 Jan 10;318(Pt B):116927. doi: 10.1016/j.jep.2023.116927. Epub 2023 Jul 31.
4
Antioxidant Versus Pro-Apoptotic Effects of Mushroom-Enriched Diets on Mitochondria in Liver Disease.富含蘑菇的饮食对肝脏疾病中线粒体的抗氧化与促凋亡作用。
Int J Mol Sci. 2019 Aug 16;20(16):3987. doi: 10.3390/ijms20163987.
5
Traditional Chinese herbal extracts inducing autophagy as a novel approach in therapy of nonalcoholic fatty liver disease.传统中草药提取物诱导自噬作为非酒精性脂肪性肝病治疗的新方法。
World J Gastroenterol. 2017 Mar 21;23(11):1964-1973. doi: 10.3748/wjg.v23.i11.1964.
6
Phytotherapy as Multi-Hit Therapy to Confront the Multiple Pathophysiology in Non-Alcoholic Fatty Liver Disease: A Systematic Review of Experimental Interventions.植物疗法作为一种多靶点治疗方法应对非酒精性脂肪性肝病的多种病理生理学:实验干预的系统评价。
Medicina (Kaunas). 2021 Aug 14;57(8):822. doi: 10.3390/medicina57080822.
7
Mechanisms of beneficial effects of exercise training on non-alcoholic fatty liver disease (NAFLD): Roles of oxidative stress and inflammation.运动训练对非酒精性脂肪性肝病(NAFLD)有益影响的机制:氧化应激和炎症的作用。
Eur J Sport Sci. 2019 Aug;19(7):994-1003. doi: 10.1080/17461391.2019.1571114. Epub 2019 Feb 8.
8
Oxidative Stress as a Critical Factor in Nonalcoholic Fatty Liver Disease Pathogenesis.氧化应激作为非酒精性脂肪性肝病发病机制中的关键因素
Antioxid Redox Signal. 2017 Apr 1;26(10):519-541. doi: 10.1089/ars.2016.6776. Epub 2016 Aug 30.
9
Mitochondria, oxidative stress and nonalcoholic fatty liver disease: A complex relationship.线粒体、氧化应激与非酒精性脂肪性肝病:一种复杂的关系。
Eur J Clin Invest. 2022 Mar;52(3):e13622. doi: 10.1111/eci.13622. Epub 2021 Jun 15.
10
Mitochondrial Oxidative Stress and Antioxidants Balance in Fatty Liver Disease.脂肪肝疾病中的线粒体氧化应激与抗氧化剂平衡
Hepatol Commun. 2018 Oct 30;2(12):1425-1439. doi: 10.1002/hep4.1271. eCollection 2018 Dec.

引用本文的文献

1
Nuclear receptors in metabolic, inflammatory, and oncologic diseases: mechanisms, therapeutic advances, and future directions.代谢、炎症和肿瘤疾病中的核受体:作用机制、治疗进展及未来方向
Eur J Med Res. 2025 Sep 9;30(1):843. doi: 10.1186/s40001-025-03073-6.
2
Unveiling the therapeutic potential of natural products in Alzheimer's disease: insights from , , and clinical studies.揭示天然产物在阿尔茨海默病中的治疗潜力:来自……及临床研究的见解
Front Pharmacol. 2025 Jun 23;16:1601712. doi: 10.3389/fphar.2025.1601712. eCollection 2025.
3
Effect of L. (saffron) and L. (rosemary) in hepatocellular carcinoma: A narrative review of current evidence and prospects.

本文引用的文献

1
Dietary carbohydrates: Pathogenesis and potential therapeutic targets to obesity-associated metabolic syndrome.膳食碳水化合物:与肥胖相关的代谢综合征的发病机制和潜在治疗靶点。
Biofactors. 2022 Sep;48(5):1036-1059. doi: 10.1002/biof.1886. Epub 2022 Sep 14.
2
Renoprotective potentials of small molecule natural products targeting mitochondrial dysfunction.靶向线粒体功能障碍的小分子天然产物的肾脏保护潜力
Front Pharmacol. 2022 Jul 15;13:925993. doi: 10.3389/fphar.2022.925993. eCollection 2022.
3
Kinsenoside alleviates inflammation and fibrosis in experimental NASH mice by suppressing the NF-κB/NLRP3 signaling pathway.
藏红花和迷迭香在肝细胞癌中的作用:当前证据与前景的叙述性综述
Iran J Basic Med Sci. 2025;28(8):986-1003. doi: 10.22038/ijbms.2025.84172.18204.
4
Oxidative stress modulation in alcohol-related liver disease: From chinese botanical drugs to exercise-based interventions.酒精性肝病中的氧化应激调节:从中草药到基于运动的干预措施
Front Pharmacol. 2025 Apr 25;16:1516603. doi: 10.3389/fphar.2025.1516603. eCollection 2025.
5
Study on secondary prevention and the impact of risk factor control on myocardial infarction events in young patients with coronary heart disease.青年冠心病患者二级预防及危险因素控制对心肌梗死事件影响的研究
Medicine (Baltimore). 2025 Mar 21;104(12):e41709. doi: 10.1097/MD.0000000000041709.
6
Diet, oxidative stress and MAFLD: a mini review.饮食、氧化应激与代谢功能障碍相关脂肪性肝病:一篇综述短文
Front Nutr. 2025 Mar 4;12:1539578. doi: 10.3389/fnut.2025.1539578. eCollection 2025.
7
REGγ deficiency ameliorates hepatic ischemia and reperfusion injury in a mitochondrial p66shc dependent manner in mice.REGγ缺乏以线粒体p66shc依赖的方式改善小鼠肝脏缺血再灌注损伤。
Transl Gastroenterol Hepatol. 2024 Oct 16;9:62. doi: 10.21037/tgh-24-46. eCollection 2024.
8
Sulforaphane regulates cell proliferation and induces apoptotic cell death mediated by ROS-cell cycle arrest in pancreatic cancer cells.萝卜硫素可调节胰腺癌细胞的细胞增殖,并诱导由活性氧介导的凋亡性细胞死亡——细胞周期停滞。
Front Oncol. 2024 Aug 29;14:1442737. doi: 10.3389/fonc.2024.1442737. eCollection 2024.
9
Advancements in Utilizing Natural Compounds for Modulating Autophagy in Liver Cancer: Molecular Mechanisms and Therapeutic Targets.利用天然化合物调控肝癌自噬的研究进展:分子机制和治疗靶点。
Cells. 2024 Jul 12;13(14):1186. doi: 10.3390/cells13141186.
10
Hovenia dulcis: a Chinese medicine that plays an essential role in alcohol-associated liver disease.枳椇子:一种在酒精性肝病中发挥重要作用的中药。
Front Pharmacol. 2024 Apr 8;15:1337633. doi: 10.3389/fphar.2024.1337633. eCollection 2024.
金雀异黄素通过抑制 NF-κB/NLRP3 信号通路减轻实验性 NASH 小鼠的炎症和纤维化。
Phytomedicine. 2022 Sep;104:154241. doi: 10.1016/j.phymed.2022.154241. Epub 2022 Jun 15.
4
Therapeutic Aspects and Molecular Targets of Autophagy to Control Pancreatic Cancer Management.自噬在胰腺癌治疗中的治疗方面及分子靶点
Biomedicines. 2022 Jun 20;10(6):1459. doi: 10.3390/biomedicines10061459.
5
Orientin Attenuated d-GalN/LPS-Induced Liver Injury through the Inhibition of Oxidative Stress via Nrf2/Keap1 Pathway.山奈酚通过 Nrf2/Keap1 通路抑制氧化应激减轻 d-半乳糖胺/脂多糖诱导的肝损伤。
J Agric Food Chem. 2022 Jul 6;70(26):7953-7967. doi: 10.1021/acs.jafc.2c02015. Epub 2022 Jun 21.
6
Role of silymarin as antioxidant in clinical management of chronic liver diseases: a narrative review.水飞蓟素作为抗氧化剂在慢性肝病临床治疗中的作用:叙述性综述。
Ann Med. 2022 Dec;54(1):1548-1560. doi: 10.1080/07853890.2022.2069854.
7
Melatonin relieves liver fibrosis induced by Txnrd3 knockdown and nickel exposure via IRE1/NF-kB/NLRP3 and PERK/TGF-β1 axis activation.褪黑素通过 IRE1/NF-κB/NLRP3 和 PERK/TGF-β1 轴的激活缓解 Txnrd3 敲低和镍暴露诱导的肝纤维化。
Life Sci. 2022 Jul 15;301:120622. doi: 10.1016/j.lfs.2022.120622. Epub 2022 May 7.
8
Paeoniflorin ameliorates diabetic liver injury by targeting the TXNIP-mediated NLRP3 inflammasome in db/db mice.丹皮酚通过靶向 db/db 小鼠中 TXNIP 介导的 NLRP3 炎性小体改善糖尿病肝损伤。
Int Immunopharmacol. 2022 Aug;109:108792. doi: 10.1016/j.intimp.2022.108792. Epub 2022 Apr 25.
9
Hepatoprotective effect of Baicalin against thioacetamide-induced cirrhosis in rats: Targeting NOX4/NF-κB/NLRP3 inflammasome signaling pathways.黄芩苷对硫代乙酰胺诱导大鼠肝纤维化的保护作用:靶向 NOX4/NF-κB/NLRP3 炎性小体信号通路。
Life Sci. 2022 Apr 15;295:120410. doi: 10.1016/j.lfs.2022.120410. Epub 2022 Feb 17.
10
Nobiletin mitigates hepatocytes death, liver inflammation, and fibrosis in a murine model of NASH through modulating hepatic oxidative stress and mitochondrial dysfunction.川陈皮素通过调节肝氧化应激和线粒体功能障碍减轻 NASH 小鼠模型肝细胞死亡、肝脏炎症和纤维化。
J Nutr Biochem. 2022 Feb;100:108888. doi: 10.1016/j.jnutbio.2021.108888. Epub 2021 Oct 22.